What is Jianmin Pharmaceutical Group Co Days Payable?
Jianmin Pharmaceutical Group CoSHSE:600976 -2.77%59 Days Payable is 195.00 as of Mar. 2026, which is 161% above its 10-year median of 74.80. GuruFocus rates SHSE:600976 with a GF Score™ of 59/100 and a GF Value™ of ¥41.60 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 922 Drug Manufacturers companies, Jianmin Pharmaceutical Group Co ranks better than 82.86% on this metric.
The historical rank and industry rank for Jianmin Pharmaceutical Group Co's Days Payable or its related term are showing as below:
SHSE:600976'
s Days Payable Range Over the Past 10 Years
Min: 47.29 Med: 74.8 Max: 186.55
Current: 186.55
During the past 13 years, Jianmin Pharmaceutical Group Co's highest Days Payable was 186.55. The lowest was 47.29. And the median was 74.80.
SHSE:600976's Days Payable is ranked better than 82.86% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.61
vs SHSE:600976: 186.55
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jianmin Pharmaceutical Group Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Jianmin Pharmaceutical Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jianmin Pharmaceutical Group Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jianmin Pharmaceutical Group Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Jianmin Pharmaceutical Group Co's Days Payable falls into.
Jianmin Pharmaceutical Group Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jianmin Pharmaceutical Group Co (SHSE:600976) has a Days Payable of 195.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jianmin Pharmaceutical Group Co and its competitors. This is 161% above median its historical median of 74.80. Over the past decade, Jianmin Pharmaceutical Group Co's Days Payable has ranged from 47.29 to 186.55. According to the industry distribution chart, Jianmin Pharmaceutical Group Co ranks #158 out of 922 companies in the Drug Manufacturers industry, placing it in the top 17.1%.
Is Jianmin Pharmaceutical Group Co's Days Payable too high?
Jianmin Pharmaceutical Group Co's current Days Payable of 195.00 is 161% above median its 10-year median of 74.80. Over the past 10 years, this metric has ranged from a low of 47.29 to a high of 186.55. The Drug Manufacturers industry median Days Payable is 90.61. Jianmin Pharmaceutical Group Co's value of 195.00 is 115.2% above this industry median. Based on the distribution chart, Jianmin Pharmaceutical Group Co ranks #158 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jianmin Pharmaceutical Group Co has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jianmin Pharmaceutical Group Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jianmin Pharmaceutical Group Co ranks #158 out of 922 companies for Days Payable. This places Jianmin Pharmaceutical Group Co in the top 17% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.61. Jianmin Pharmaceutical Group Co's value of 195.00 is 115.2% above this benchmark. Historically, Jianmin Pharmaceutical Group Co's own Days Payable has ranged from 47.29 to 186.55 over the past decade. While the company's 10-year median is 74.80 vs. the industry median of 90.61, Jianmin Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.61, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jianmin Pharmaceutical Group Co's current Days Payable of 195.00 is 115.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jianmin Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jianmin Pharmaceutical Group Co's current Days Payable is 195.00, which is 161% above median its own 10-year median of 74.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jianmin Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Jianmin Pharmaceutical Group Co (SHSE:600976) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥41.60, compared to a current price of ¥28.10 — trading 32.5% below its estimated fair value. The current Days Payable is 195.00, which is 161% above median its 10-year median of 74.80 and 115.2% above the Drug Manufacturers industry median of 90.61. Jianmin Pharmaceutical Group Co's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Jianmin Pharmaceutical Group Co (SHSE:600976), the current Days Payable is 195.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jianmin Pharmaceutical Group Co (SHSE:600976) Overvalued in 2026?
Based on GuruFocus' analysis, Jianmin Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥28.10 is trading 32.5% below its estimated GF Value™ of ¥41.60.
GuruFocus considers Jianmin Pharmaceutical Group Co to be Significantly Undervalued.
Key valuation signals for SHSE:600976:
Days Payable: 195.00 (161% above median its 10-year median of 74.80)
GF Value™: ¥41.60 vs. price of ¥28.10 (32.5% below fair value)
Industry Position: 115.2% above the Drug Manufacturers median (#158 of 922)
No single metric tells the full story. See the SHSE:600976 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jianmin Pharmaceutical Group Co Business Description
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
59GF Score
Get the complete analysis for SHSE:600976
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600976 has been successfully added to your 
